Acetyl levocarnitine hydrochloride,Bacopa monnieri,Calcium folinate,Camellia sinensis,Cyanocobalamin,Magnesium amino acid chelate,pyridoxal 5-phosphate,Potassium iodide,Serine,Tyrosine,Zinc sulfate monohydrate - search results

designs for health pty ltd - acetyl levocarnitine hydrochloride,glutamine,levomefolate glucosamine,magnesium amino acid chelate,magnesium glycerophosphate,magnesium orotate,mecobalamin (co-methylcobalamin),nicotinamide,pyridoxal 5-phosphate,riboflavin sodium phosphate,taurine,thiamine hydrochloride -

United States - English - NLM (National Library of Medicine)

acetylcysteine injection, solution

sagent pharmaceuticals - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine injection is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion (rsi). acetylcysteine is contraindicated in patients with a previous hypersensitivity reaction to acetylcysteine [see warnings and precautions (5.1)] . risk summary limited published case reports and case series of pregnant women exposed to acetylcysteine during various trimesters are not sufficient to inform any drug associated risk. delaying treatment of acetaminophen overdose may increase the risk of maternal or fetal morbidity and mortality [see clinical considerations]. reproduction studies in rats and rabbits following oral administration of acetylcysteine during the period of organogenesis at doses similar to the total intravenous dose (based on the body surface area) did not cause any adverse effects to the fetus. the estimated background risk of major birth defects and miscarriage